MktsMarkets

Mustang Bio, Inc.
NASDAQ: MBIOKey statistics
MBIO News
Stories mentioning MBIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 1,058 | 670.00 | 624.00 | 885.00 | 253.00 | 1,017 | 1,457 | 8,540 |
| Operating Income (Loss) | (1,058) | (670.00) | (624.00) | (885.00) | (253.00) | (1,017) | (1,457) | (8,540) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (955.00) | (538.00) | (468.00) | (762.00) | (153.00) | (952.00) | (1,410) | (8,199) |
| Earnings Per Share (Basic) | (0.14) | (0.11) | (0.07) | (0.19) | (0.05) | (1.56) | (1.96) | (18.36) |
| Earnings Per Share (Diluted) | (0.14) | (0.11) | (0.07) | (0.19) | (0.05) | (1.56) | (1.96) | (18.36) |
| Weighted Average Shares Outstanding (Basic) | 6,730 | 4,908 | 6,242 | 4,021 | 2,861 | 610.00 | 721.00 | 447.00 |
| Weighted Average Shares Outstanding (Diluted) | 6,730 | 4,908 | 6,242 | 4,021 | 2,861 | 610.00 | 721.00 | 447.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MBIO
Mustang Bio, Inc. (NASDAQ: MBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol MBIO. It last traded at $0.3900 (Nov 6, 2026, 4:00 PM ET), up 0.1% on the day. That gives Mustang Bio a market capitalisation of $3.0M.
Over the past 52 weeks MBIO has traded between $0.3500 and $1.43.
For the quarter ended Mar 31, 2026 it reported a net loss of $955.0K.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$955.0K |
| Dec 31, 2025 | — | -$538.0K |
| Sep 30, 2025 | — | -$468.0K |
| Jun 30, 2025 | — | -$762.0K |
From Mustang Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…